Medical Therapy. Efficacy or Lack of Efficacy

Two Cases of Congenital Chylethorax: A Successful Story of Medical Management

I. Kankananarachchi, K. K. S. Priyankara, K. K. K. Lakman, K. Withanaarachchi, P. K. G. GunathilakaUniversity of Ruhuna. Teaching Hospital Karapitiya. Sri Lanka Case Reports in PediatricsCase Rep Pediatr 2021; DOI: 10.1155/2021/6634326 AbstractCongenital chylothorax (CC) is one of the most common causes of pleural effusions in neonates. Associated ipsilateral pulmonary aplasia in CC results in neonatal […]

Two Cases of Congenital Chylethorax: A Successful Story of Medical Management Read More »

A case of refractory chylothorax treated with Eppikajutsuto

Juma Obayashi, Shigeyuki Furuta, Yukitsugu Nakamura, Kunihide Tanaka, Hiroaki KitagawaSt. Marianna University School of Medicine. Japan Pediatrics InternationalPediatr Int 2022; 64: DOI: 10.1111/ped.14707 AbstractNo Abstract Available CategoryPrimary Pulmonary Lymphatic DiseaseGenetic Factors Associated with Pulmonary Vascular DiseaseMedical Therapy. Efficacy or Lack of Efficacy Age Focus: Pediatric Pulmonary Vascular Disease Fresh or Filed Publication: Filed (PHiled). Greater than

A case of refractory chylothorax treated with Eppikajutsuto Read More »

Staged Management of Congenital Chylothorax With Hydrops Fetalis: An Insight Into EXIT Related Procedures

Hung-Lin Tai, Tze Yee Diane Mok, An-Shine Chao, Shih-Ming Chu, Reyin LienSaint Paul’s Hospital. Chang Gung Memorial Hospital. New Taipei Municipal TuCheng Hospital. Chang Gung Medical Center and Chang Gung University.Taiwan Frontiers in PediatricsFront Pediatr 2021; DOI: 10.3389/fped.2021.633051 AbstractBackground: Idiopathic congenital chylothorax is a rare but serious disease. Advancement in perinatal care and the renovated treatment modalities

Staged Management of Congenital Chylothorax With Hydrops Fetalis: An Insight Into EXIT Related Procedures Read More »

Outcomes of neonatal chylous effusions: A 20-year west-Australian tertiary center experience

A. Anvekar, G. Athalye-Jape, H. Panchal, S. Rao, R. KohanFiona Stanley Hospital. King Edward Memorial Hospital. Perth Children Hospital.Australia LymphologyLymphology 2021; 54: 204-213DOI Not Available AbstractNeonatal chylous effusions are rare entity with limited evidence-based management. We conducted a retrospective review of neonates admitted to King Edward Memorial and Princess Margaret/Perth Children’s Hospital over 20 years

Outcomes of neonatal chylous effusions: A 20-year west-Australian tertiary center experience Read More »

Use of Propranolol in the Treatment of Chylous Effusions in Infants

Kaitlin Mitchell, Angela Weiner, Patricia Ramsay, Mitali SahniPediatrix Medical Group of Nevada and University of Nevada.United States PediatricsPediatrics 2021; 148: DOI: 10.1542/peds.2020-049699 AbstractChylothorax and chyloperitoneum are rare in infants and challenging to definitively diagnose by using current criteria extrapolated from the adult population. They can be of primary or secondary etiologies, including congenital lymphatic malformations and

Use of Propranolol in the Treatment of Chylous Effusions in Infants Read More »

Dietary treatment of congenital chylothorax with skimmed breast milk

Michaela Höck, Alexander Höller, Marlene Hammerl, Karina Wechselberger, Jakob Krösslhuber, Ursula Kiechl-Kohlendorfer, Sabine Scholl-Bürgi, Daniela KarallMedical University of Innsbruck. Austria Italian Journal of PediatricsItal J Pediatr 2021; 47: DOI: 10.1186/s13052-021-01125-1 AbstractBackground: Congenital chylothorax (CC) is a rare but potentially life-threatening condition in newborns. It is defined as an accumulation of chyle in the pleural cavity. The few

Dietary treatment of congenital chylothorax with skimmed breast milk Read More »

The use of high dose octreotide in management of neonatal chylothorax: Review

M. A. AlhasoonUnaizah College of Medicine and Medical Sciences and Qassim University.Saudi Arabia Journal of Neonatal and Perinatal MedicineJ Neonatal Perinatal Med 2021; 14: 457-461DOI: 10.3233/NPM-200644 AbstractBackground: Being a rare condition, the incidence of chylothorax among neonates is low, but the mortality rate is high. In a dire effort to reduce the risk of death, octreotide treatment

The use of high dose octreotide in management of neonatal chylothorax: Review Read More »

Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders

Emmanuel Mas, Osvaldo Borrelli, Ilse Broekaert, J. Martin de-Carpi, Jernej Dolinsek, Erasmo Miele, Corina Pienar, C. Ribes Koninckx, Ruth-Anne Thomassen, Mike Thomson, Christo Tzivinikos, Marc A. BenningaHôpital des Enfants and Université de Toulouse. Great Ormond Street Hospital. University Hospital Cologne and University of Cologne. Hospital Sant Joan de Déu. University Medical Centre Maribor. University of

Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders Read More »

Adjunct Targeted Biologic Inhibition Agents to Treat Aggressive Multivessel Intraluminal Pediatric Pulmonary Vein Stenosis

Ryan Callahan, Mark W. Kieran, Christopher W. Baird, Steven D. Colan, Kimberlee Gauvreau, Chistina M. Ireland, Audrey Marshall, Laureen M. Sena, Sara O. Vargas, Kathy J. JenkinsBoston Children’s Hospital and Harvard Medical School. Floating Hospital for Children at Tufts Medical Center. UMass Memorial Medical Center.United States Journal of PediatricsJ Pediatr 2018; 198: 29-35DOI: 10.1016/j.jpeds.2018.01.029 AbstractObjective: To evaluate

Adjunct Targeted Biologic Inhibition Agents to Treat Aggressive Multivessel Intraluminal Pediatric Pulmonary Vein Stenosis Read More »

Intervening with the Nitric Oxide Pathway to Alleviate Pulmonary Hypertension in Pulmonary Vein Stenosis

Richard W. B. van Duin, Kelly Stam, André Uitterdijk, Beatrijs Bartelds, A. H. Jan Danser, Irwin K. M. Reiss, Dirk J. Duncker, Daphne MerkusErasmus MC Rotterdam. Sophia Children’s Hospital. University Hospital, LMU Munich.Netherlands and Germany Journal of Clinical MedicineJ Clin Med 2019; 8: DOI: 10.3390/jcm8081204 AbstractPulmonary hypertension (PH) as a result of pulmonary vein stenosis (PVS)

Intervening with the Nitric Oxide Pathway to Alleviate Pulmonary Hypertension in Pulmonary Vein Stenosis Read More »

Scroll to Top